Euromedica General Clinic Of Thessaloniki

The Euromedica General Clinic Of Thessaloniki is active in neoplasms, with studies focused on cancers such as non-small cell lung cancer, breast cancer, endometrial cancer, ovarian cancer, and colorectal cancer. Research here is largely aimed at testing new treatment approaches, improving disease control, and understanding how targeted and immunotherapy-based strategies may help patients with advanced or treatment-resistant disease.

• Advanced lung cancer and small cell lung cancer research exploring new anti-tumor therapies
• Breast cancer studies in hormone receptor-positive and HER2-negative disease, including metastatic and brain-metastatic settings
• Gynecologic cancers such as endometrial, ovarian, cervical, and fallopian tube cancer
• Colorectal cancer and other solid tumor trials assessing targeted treatment effectiveness

These studies reflect a strong focus on personalized oncology, with the site contributing to research that may refine how advanced cancers are treated and monitored.

This site has a major research presence in nutritional and metabolic diseases, especially type 2 diabetes, obesity, and overweight. Trials are examining whether newer therapies can improve blood sugar control, support weight management, and reduce long-term complications linked to metabolic disease.

• Type 2 diabetes studies in adults and adolescents
• Obesity and overweight research linked to metabolic risk reduction
• Trials looking at better glycaemic control and overall treatment effectiveness
• Research on therapies that may support both diabetes management and cardiovascular protection

The Department of Endocrinology at the clinic appears especially active in studies that connect metabolic disease treatment with broader health outcomes, including heart and kidney health.

Within cardiovascular diseases, the clinic is involved in research on atherosclerotic cardiovascular disease, hypertension, elevated Lp(a), and heart-kidney complications in people with type 2 diabetes. These trials are designed to evaluate whether emerging therapies can lower the risk of major cardiovascular events and improve long-term organ protection.

• Cardiovascular disease prevention and risk reduction studies
• Hypertension and diabetes combined-risk research
• Trials focused on heart failure, kidney outcomes, and major adverse cardiovascular events
• Studies assessing treatment value in people with elevated lipoprotein(a)

These projects highlight an emphasis on preventing complications before they become irreversible, particularly in people already living with metabolic disease.

The site also contributes to nervous system diseases research, with several studies centered on Alzheimer’s disease, mild cognitive impairment, and related behavioral symptoms such as agitation. The main goal is to evaluate treatments that may improve cognition, function, and quality of life for patients and caregivers.

• Alzheimer’s disease and mild dementia studies
• Research on agitation linked to dementia
• Trials assessing whether therapies can support cognitive function and daily living
• Work aimed at better symptom management in neurodegenerative disease

At Euromedica General Clinic Of Thessaloniki, this field reflects a growing interest in treatments that address both memory decline and difficult behavioral symptoms.

Another active area is respiratory tract diseases, especially non-small cell lung cancer, small cell lung cancer, and non-cystic fibrosis bronchiectasis. The research is aimed at testing new therapies, improving control of advanced lung disease, and evaluating options that may better address symptoms and disease progression.

• Non-small cell lung cancer trials, including cases with specific genetic features
• Small cell lung cancer research focused on anti-tumor activity
• Bronchiectasis studies exploring symptom and exacerbation reduction
• Investigations of treatment effectiveness in advanced respiratory disease

This respiratory portfolio shows a mix of oncology and chronic lung disease research, supporting both cancer care and broader pulmonary medicine.

In the area of female urogenital diseases and pregnancy complications, the clinic is involved in studies of endometrial cancer, ovarian epithelial cancer, cervical cancer, and other advanced gynecologic malignancies. The purpose of these trials is to improve treatment effectiveness, delay recurrence, and support better outcomes in difficult-to-treat disease.

• Endometrial cancer and recurrent advanced disease
• Ovarian, fallopian tube, and primary peritoneal cancer research
• Cervical cancer studies evaluating combined treatment approaches
• Trials focused on disease control and extending progression-free survival

These studies add an important women’s health dimension to the site’s broader oncology program.

The clinic’s research in psychiatry and psychology includes studies on agitation in Alzheimer’s disease and related dementia conditions. The aim is to assess whether new therapies can better manage behavioral symptoms while remaining safe and tolerable for patients.

• Agitation in dementia and Alzheimer’s-related conditions
• Research on symptom relief and day-to-day behavioral stability
• Studies evaluating overall safety, tolerability, and treatment benefit
• Work supporting more practical care for patients and families

This area complements the site’s neurology portfolio by addressing the psychological and behavioral challenges that often accompany cognitive decline.